Martin P Alphonse Selected Research

Martin P Alphonse Research Topics

Disease

7	Infections 02/2024 - 01/2019
7	Inflammation (Inflammations) 02/2024 - 02/2007
4	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2021
3	Asthma (Bronchial Asthma) 01/2021 - 02/2007
2	Bacterial Infections (Bacterial Infection) 02/2024 - 01/2022
2	Wounds and Injuries (Trauma) 01/2023 - 11/2021
2	Prurigo 01/2022 - 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Soft Tissue Infections 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Arteritis 01/2023
1	Dermatitis 01/2023
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2023
1	Staphylococcal Infections 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Neoplasms (Cancer) 04/2022
1	Abscess 01/2022
1	Dysbiosis 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Allergic Rhinitis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Pruritus (Itching) 01/2021
1	Coinfection 11/2019
1	Aneurysm (Aneurysms) 12/2016

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2023
3	CytokinesIBA 02/2024 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2021
3	Immunoglobulin E (IgE)IBA 01/2021 - 02/2007
2	CaspasesIBA 08/2023 - 01/2021
2	AllergensIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 08/2023
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 08/2023
1	crisaboroleIBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Filaggrin ProteinsIBA 01/2023
1	Phosphodiesterase 4 InhibitorsIBA 01/2023
1	InflammasomesIBA 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	MercuryIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 04/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	Drug CombinationsIBA 04/2022
1	butyl phosphorotrithioate (DEF)IBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	Interleukin-13IBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	PeriostinIBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	DefensinsIBA 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	quinoline-val-asp(OMe)-CH2-OPHIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	KetonesIBA 01/2021
1	quinolineIBA 01/2021
1	LuciferasesIBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2016
1	IgE Receptors (Fc epsilon RI)IBA 04/2008

Therapy/Procedure

3	Immunotherapy 02/2024 - 01/2021
3	Therapeutics 08/2023 - 01/2023